Index
Module 15 • Shock & Hemodynamics
Shock Syndromes I
89%
Core Content
Shock Syndromes I
Gretchen L. Sacha ~4 min read Module 15 of 20
57
/ 64

Shock Syndromes I

Med.

2017;195(7):906-911.

https://doi.org/10.1164/

rccm.201604-0854oc

De Backer D, Biston P, Devriendt J, et al. Comparison

of dopamine and norepinephrine in the treatment of

shock. N Engl J Med. 2010;362(9):779-789. https://doi.

org/10.1056/nejmoa0907118

De Backer D, Creteur J, Dubois MJ, et al. The effects of

dobutamine on microcirculatory alterations in patients

with septic shock are independent of its systemic

effects. Crit Care Med. 2006;34(2):403-408. https://doi.

org/10.1097/01.ccm.0000198107.61493.5a

Delaney AP, Dan A, McCaffrey J, Finfer S. The role

of albumin as a resuscitation fluid for patients with

sepsis: a systematic review and meta-analysis. Crit

Care Med. 2011;39(2):386-391. https://doi.org/10.1097/

ccm.0b013e3181ffe217

Evans L, Rhodes A, Alhazzani W, et al. Surviving

Sepsis Campaign: international guidelines for man-

agement of sepsis and septic shock 2021. Crit Care

Med. 2021;49(11):e1063-e1143. https://doi.org/10.1097/

ccm.0000000000005337

Finfer S, Bellomo R, Boyce N, et al. A comparison of

albumin and saline for fluid resuscitation in the inten-

sive care unit. N Engl J Med. 2004;350(22):2247-2256.

https://doi.org/10.1056/nejmoa040232

Fowler AA 3rd, Truwit JD, Hite RD, et al. Effect of

vitamin C infusion on organ failure and biomarkers of

inflammation and vascular injury in patients with sep-

sis and severe acute respiratory failure: the CITRIS-ALI

randomized clinical trial. JAMA. 2019;322(13):1261-

1270. https://doi.org/10.1001/jama.2019.11825

Frazee EN, Leedahl DD, Kashani KB. Key controver-

sies in colloid and crystalloid fluid utilization. Hosp

Pharm.

2015;50(6):446-453.

https://doi.org/10.1310/

hpj5006-446

Fujii T, Luethi N, Young PJ, et al. Effect of vitamin C,

hydrocortisone, and thiamine vs hydrocortisone alone

on time alive and free of vasopressor support among

patients with septic shock: the VITAMINS randomized

clinical trial. JAMA. 2020;323(5):423-431. https://doi.

org/10.1001/jama.2019.22176

Gaieski DF, Edwards JM, Kallan MJ, Carr BG.

Benchmarking the incidence and mortality of severe

sepsis in the United States. Crit Care Med. 2013;41(5):1167-

1174. https://doi.org/10.1097/ccm.0b013e31827c09f8

Gattinoni L, Brazzi L, Pelosi P, et al. A trial of

goal-oriented hemodynamic therapy in critically ill

patients. SvO2 Collaborative Group. N Engl J Med.

1995;333(16):1025-1032.

https://doi.org/10.1056/

nejm199510193331601

Gordon AC, Mason AJ, Thirunavukkarasu N, et al.

Effect of early vasopressin vs norepinephrine on kid-

ney failure in patients with septic shock: the VANISH

randomized clinical trial. JAMA. 2016;316(5):509-518.

https://doi.org/10.1001/jama.2016.10485

Hammond

DA,

Lam

SW,

Rech

MA,

et

al.

Balanced

crystalloids

versus

saline

in

critically ill adults: a systematic review and meta-anal-

ysis. Ann Pharmacother. 2020;54(1):5-13. https://doi.

org/10.1177/1060028019866420

Hernández G, Ospina-Tascón GA, Damiani LP, et

al. Effect of a resuscitation strategy targeting periph-

eral perfusion status vs serum lactate levels on 28-day

mortality among patients with septic shock: the

ANDROMEDA-SHOCK randomized clinical trial.

JAMA. 2019;321(7):654-664. https://doi.org/10.1001/

jama.2019.0071

Holst LB, Haase N, Wetterslev J, et al. Lower versus

higher hemoglobin threshold for transfusion in septic

shock. N Engl J Med. 2014;371(15):1381-1391. https://doi.

org/10.1056/nejmoa1406617

Indian Health Service. Disparities. US Department of

Health and Human Services. Disparities | Fact Sheets

Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early

lactate-guided therapy in intensive care unit patients: a

multicenter, open-label, randomized controlled trial. Am

J Respir Crit Care Med. 2010;182(6):752-761. https://doi.

org/10.1164/rccm.200912-1918oc

Jones AE, Shapiro NI, Trzeciak S, et al. Lactate clear-

ance vs central venous oxygen saturation as goals

of early sepsis therapy: a randomized clinical trial.

JAMA.

2010;303(8):739-746.

https://doi.org/10.1001/

jama.2010.158

Jones JM, Fingar KR, Miller MA, et al. Racial dis-

parities in sepsis-related in-hospital mortality: using

a broad case capture method and multivariate controls

for clinical and hospital variables, 2004-2013. Crit Care

Med. 2017;45(12):e1209-e1217. https://doi.org/10.1097/

ccm.0000000000002699

HD Video Explanation — Synchronized with PDF
Starts at: minute 56 Open on YouTube